Ocumension Therapeutics

HK$5.05As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1477Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 6Y CAGR (24.51%)
Div yield —
ROE (3.45%)
Biotechnology
Beta (5Y) 0.46
PE TTM —
TSR TTM (39.52%)
Mkt cap HK$4.118B
ROIC (2.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.89
16.63%
(88.72%)
Hold 11|2|8|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.07
0.08
36.72%
40.50%
32.71%
32.28%
Revenue¥M
433.0
453.0
455.5
458.4
3.27%
2.65%
4.41%
2.75%
Peers (US$525.2M)
Cap (US$)
PE
526.1M
63.33x
Capital
TTM
5Y
10Y
Leveragex
1.186
(1.372)
(1.188)
EBIT/Intx
0.186
0.245
0.193
Own earn%
43.76
(202.25)
(143.41)
Sh yield%
15.83
9.29
8.34
Owners
Insiders/Inst%
8.39
71.09
Short interest%
4.31
SBC / revenue%
1.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
0–3
$1 testx
0.0
Incr. ROIC%
2